Detalhe da pesquisa
1.
Antibody effector functions are associated with protection from respiratory syncytial virus.
Cell
; 185(26): 4873-4886.e10, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513064
2.
Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults.
N Engl J Med
; 388(7): 609-620, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791161
3.
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF-Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study.
J Infect Dis
; 229(1): 19-29, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433021
4.
Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine.
J Virol
; 97(11): e0077123, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37902399
5.
Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and High-dose Influenza Vaccine in Adults 65 Years and Older: a Noninferiority Trial.
J Infect Dis
; 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134393
6.
Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study.
J Infect Dis
; 226(4): 595-607, 2022 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32939546
7.
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months.
J Infect Dis
; 227(1): 71-82, 2022 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259542
8.
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study.
J Infect Dis
; 226(3): 396-406, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400792
9.
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
J Infect Dis
; 223(4): 699-708, 2021 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32851411
10.
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years.
J Infect Dis
; 222(6): 979-988, 2020 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320465
11.
Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.
Hepatology
; 63(5): 1442-54, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26513111
12.
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).
Proc Natl Acad Sci U S A
; 110(37): 15001-6, 2013 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23980172
13.
Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
JAMA
; 315(15): 1610-23, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27092831
14.
T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.
Hepatology
; 60(5): 1531-40, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24975498
15.
Long-term efficacy and immunogenicity of Ad26.RSV.preF-RSV preF protein vaccine (CYPRESS): a randomised, double-blind, placebo-controlled, phase 2b study.
Lancet Infect Dis
; 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38801826
16.
Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life.
Hum Vaccin Immunother
; 20(1): 2344970, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38783590
17.
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.
Vaccines (Basel)
; 11(3)2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992257
18.
Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire™ symptom scores.
J Patient Rep Outcomes
; 7(1): 51, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37261682
19.
Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models.
NPJ Vaccines
; 8(1): 45, 2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949051
20.
Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans.
Front Immunol
; 14: 1215302, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37727795